Literature DB >> 1484888

Histamine release inhibition activity of bisbenzylisoquinoline alkaloids.

K Nakamura1, S Tsuchiya, Y Sugimoto, Y Sugimura, Y Yamada.   

Abstract

Eleven examples of bisbenzylisoquinoline alkaloids (head-to-head; 10, head-to-tail; 1) and one half molecule type (N-methylcoclaurine), were tested by in vitro histamine release inhibition assay. The order of the potency of the inhibitory effect was ranked thus: homoaromoline, aromoline, isotetrandrine, cepharanthine, fangchinoline, obaberine, and tetrandrine. The following substances, cepharanoline, berbamine, oxyacanthine, and cycleanine (head-to-tail structure) had no inhibitory effect. N-Methylcoclaurine showed an inhibitory effect comparable to that of fangchinoline.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484888     DOI: 10.1055/s-2006-961536

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  8 in total

1.  Ameliorative effect of alkaloid extract of Cyclea peltata (Poir.) Hook. f. & Thoms. roots (ACP) on APAP/CCl4 induced liver toxicity in Wistar rats and in vitro free radical scavenging property.

Authors:  Varghese Jancy Shine; Panikamparambil Gopalakrishnan Latha; Somasekharan Nair Rajam Suja; Gangadharan Indira Anuja; Gopan Raj; Sreedharan Nair Rajasekharan
Journal:  Asian Pac J Trop Biomed       Date:  2014-02

2.  Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression.

Authors:  Xue Luo; Jian-Ming Peng; Lan-DI Su; Dong-Yan Wang; You-Jiang Yu
Journal:  Exp Ther Med       Date:  2015-12-04       Impact factor: 2.447

3.  Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage.

Authors:  Dorota Halicka; Masamichi Ita; Toshiki Tanaka; Akira Kurose; Zbigniew Darzynkiewicz
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

4.  Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.

Authors:  Masamichi Ita; H Dorota Halicka; Toshiki Tanaka; Akira Kurose; Barbara Ardelt; Kuslima Shogen; Zbigniew Darzynkiewicz
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

5.  Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.

Authors:  Feng Tian; Ding Ding; Dandan Li
Journal:  Int J Oncol       Date:  2015-04-09       Impact factor: 5.650

6.  Fangchinoline induces G0/G1 arrest by modulating the expression of CDKN1A and CCND2 in K562 human chronic myelogenous leukemia cells.

Authors:  Yuping Wang; Jie Chen; Lin Wang; Yuji Huang; Ye Leng; Guiying Wang
Journal:  Exp Ther Med       Date:  2013-01-24       Impact factor: 2.447

7.  Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha.

Authors:  W K Seow; K Nakamura; Y Sugimura; Y Sugimoto; Y Yamada; D P Fairlie; Y H Thong
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

Review 8.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.